Ibyiciro by'imanza

Urubanza rw'ingenzi

Lymphoma nini ya B-cell lymphoma (DLBCL)-04

Uburyo bwo kuvura indwara ya Myasthenia Gravis (MG) bwa CAR-T

Ubuvuzi bwa Virusi ya Oncolytic: Ubuvuzi bwa Kanseri bugezweho

Umuhungu urwaye kanseri y'amaraso ikabije (Acute lymphoblastic Leukemia)

Gutsinda Lymphoma nini ya B-cell ikwirakwira hakoreshejwe uburyo bwa Bioocus Dual CAR-T Therapy

Kurwanya kanseri y'umwijima hakoreshejwe uburyo bwa Bioocus GPC3 CAR-T Therapy

$Igisubizo gitangaje mu ndwara ya Myeloma nyinshi ya Refractory nyuma yo kuvura CAR-T cell therapy$

Igisubizo gitangaje mu ndwara ya Myeloma nyinshi ya Refractory nyuma yo kuvura CAR-T cell therapy

Intsinzi ya Madhavan: Gutsinda Glioma yo mu bwonko hakoreshejwe Bioocus B7H3 CAR-T Therapy

Umuhungu muto w’umunyembaraga wo mu Burusiya arwana n’indwara ya neuroblastoma

Umugabo w’intwari ukomoka mu Buhinde arwana na kanseri y’igifu

Bwana C ---- Diffuse Large B-cell Lymphoma (DLBCL)

Izina: Bwana C

Igitsina: Umugabo

Imyaka: 55

Ubwenegihugu: Umuhinde

Isuzuma: Lymphoma nini ya B-cell (DLBCL) ikwirakwira mu maraso

Twandikire

Uyu murwayi, Bwana C, akomoka mu Buhinde akaba afite imyaka 55. Mu ntangiriro za 2019, yarwaye indwara ya lymphadenopathy idakira, maze ajya kwa muganga mu kigo cyacu. Hakozwe isuzuma rikomeye, bituma hasuzumwa Diffuse Large B-Cell Lymphoma (DLBCL). Bitewe n’imiterere ikomeye ya DLBCL, gutangira kuvurwa byihutirwa byari ingenzi kugira ngo ikibazo gikemuke neza.

Mbere yo kuvurwa na CAR-T, Bwana C yanyuze mu buvuzi butandukanye bwo kwa muganga bujyanye n'uburyo butandukanye bwo kuvura kanseri. Mbere na mbere, yahawe RCHOP nk'ubuvuzi bwa mbere, hakurikiraho ubundi buvuzi burimo REPOCH, R2-ICE, GEMOX-BTKi, Pola-BR, GB261, TQB2916, GA 101-Cedarbenamine-Doxil, hanyuma Inotuzumab. Nubwo ubu buvuzi bwatanzwe igihe kirekire kandi bwagaragaje akamaro, bwananiwe kugera ku kurwanya indwara, bishimangira imiterere y'ubukana bwa DLBCL ya Bwana C.

Bitewe n’uko nta buryo bushimishije bwo kuvura busanzwe bwagaragaye kandi indwara ye igakomeza kwihuta, Bwana C yagaragaye nk'umukandida wo kuvurwa na CAR-T cell therapy. Nyuma yo kwitegura neza, Bwana C yavuwe na CAR-T cell therapy mu ntangiriro za 2020. Ubu buryo bushya bwo kuvura burimo guhindura uturemangingo twa T tw'umurwayi kugira ngo twibasire kandi twibasire uturemangingo twa kanseri neza.

Nyuma y'iminsi makumyabiri n'umunani nyuma yo kongera kwinjiza uturemangingo twa CAR-T, hagaragaye ko indwara zagabanutse cyane, bigaragaza ko uburyo bwo kuvura bwagenze neza. Ibi byazanye icyizere n'icyizere kuri Bwana C n'itsinda rye ry'ubuvuzi. Uburyo butangaje bwo kuvura CAR-T bugaragaza ubushobozi bwo kuvura indwara ziterwa n'ubudahangarwa bw'umubiri mu kuvura kanseri ikomeye yo mu maraso nka DLBCL.

Mu gihe kiri imbere, Bwana C azakomeza gukurikiranwa no gukurikiranwa kugira ngo akurikirane neza indwara ye. Kurwanya indwara mu gihe kirekire no kuzigama ni intego z'ingenzi muri gahunda ye yo gukomeza kwita ku barwayi. Umusaruro mwiza wavuye mu buvuzi bwa CAR-T ugaragaza akamaro k'uburyo bwihariye kandi bugezweho mu kuvura kanseri zikomeye, bigatanga amahirwe meza ku barwayi nka Bwana C.

Mbere n'iminsi 28 nyuma

ibisobanuro2

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.